格尔德霉素是以Hsp90为靶目标的安莎类抗生素,具有多种生物活性。其抗肿瘤活性使其成为目前肿瘤治疗领域的研究热点。综述了格尔德霉素生物合成及结构改良研究进展,并对其作为新型抗肿瘤药物的未来发展方向进行了讨论。
Geldanamycin, being a kind of ansamycin antibiotics that takes heat shock protein Hsp 90 as targets possesses multiple bioactivities. Its anti-tumor activity has made it to become a hot research spot in the field of tumor therapeutics. Research progress on its biosynthesis and structure reformation as well as regarding it as future development direction of new type antitumor medicine was summarized in this naner.